NUVISAN
About us
Your dedicated partner of choice
The NUVISAN group is a full-service contract research and development and manufacturing organization (CRO/CDMO) with state-of-the-art laboratories in Germany and France.
Our pharmaceutical, biotechnology, venture capital and non-profit clients partner with us because our high-quality end-to-end solutions and scientific expertise enable us to streamline and accelerate drug discovery and development – from ensuring target understanding to helping bring therapeutics to life.
Founded over 40 years ago by a team of pharma industry innovators, Nuvisan has built our reputation on a legacy of expertise and professionalism. Our team leaders have extensive experience in the biopharma industry, and our unique centres of excellence – for drug discovery in Berlin, topical dermatology in Sophia-Antipolis, and our bioanalysis hub in Neu-Ulm – enable our seasoned veterans to help guide and advance projects. We know how to discover, develop and bring the next generation of medicines to market. At the same time, we are committed to flexibility, transparency and collaboration in our approach, working closely with you to adapt to your individual needs, minimise risks, and help deliver your project.
Address
Muellerstraße 178
13353 Berlin
Germany
E-mail: hello@nuvisan.com
Phone: +49 173 7645154
Internet: www.nuvisan.com
Contact person:
PhD Juliette Pabst
Business Development Manager
E-mail: juliette.pabst@nuvisan.com
Charlotte Kopitz
Head of BU Discovery Research & Site Head
E-mail: charlotte.kopitz@nuvisan.com
Products & Services
Your partner of choice in bringing therapeutics to life
In your quest to advance health care, the right partner can make all the difference.
Discovery:
Helping you to achieve key decision milestones through deep scientific insights, innovation and collaboration.
Preclinical:
Enabling you to successfully develop and de-risk your preclinical candidates for a smooth transition to the clinic.
CMC:
Collaborating with you to advance molecules into drug products.
Clinical:
Providing tailored clinical solutions to fully assess your drug faster.
Digital:
Empowering your drug discovery and development with integrated data services, machine learning and generative AI.